BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yun U, Bae S, Song Y, Kim Y. A Critical YAP in Malignancy of HCC Is Regulated by Evodiamine. IJMS 2022;23:1855. [DOI: 10.3390/ijms23031855] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao S, Jiang X, Wang L, Jiang S, Luo H, Chen Y, Peng C. The pathogenesis of liver cancer and the therapeutic potential of bioactive substances. Front Pharmacol 2022;13:1029601. [DOI: 10.3389/fphar.2022.1029601] [Reference Citation Analysis]
2 Zhang G, Lv X, Yang Q, Liu H. Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma. BMC Cancer 2022;22:888. [PMID: 35964022 DOI: 10.1186/s12885-022-09987-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Su C, Cheng Y, Chang Y, Kung T, Chen Y, Lai K, Hsieh H, Chen C, Hwang T, Yang Y. Untargeted LC-MS/MS-Based Multi-Informative Molecular Networking for Targeting the Antiproliferative Ingredients in Tetradium ruticarpum Fruit. Molecules 2022;27:4462. [DOI: 10.3390/molecules27144462] [Reference Citation Analysis]
4 Song Y, Jang B, Lee S, Bae S, Bak S, Kim Y. Angelica gigas NAKAI and Its Active Compound, Decursin, Inhibit Cellular Injury as an Antioxidant by the Regulation of AMP-Activated Protein Kinase and YAP Signaling. Molecules 2022;27:1858. [DOI: 10.3390/molecules27061858] [Reference Citation Analysis]